Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-26-118559
Filing Date
2026-03-23
Accepted
2026-03-23 07:47:13
Documents
16
Effectiveness Date
2026-03-23

Document Format Files

Seq Description Document Type Size
1 S-8 xlo-20260323.htm S-8 133876
2 EX-5.1 xlo-ex5_1.htm EX-5.1 16823
3 EX-23.1 xlo-ex23_1.htm EX-23.1 5858
4 EX-FILING FEES xlo_exfilingfees.htm   iXBRL EX-FILING FEES 62628
5 GRAPHIC img93040053_0.jpg GRAPHIC 35924
6 GRAPHIC img93040053_1.jpg GRAPHIC 263664
7 GRAPHIC img93040053_2.jpg GRAPHIC 35924
  Complete submission text file 0001193125-26-118559.txt   810860

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT xlo_exfilingfees_htm.xml XML 9460
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-294515 | Film No.: 26779920
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)